Atlas Trials

Randomized Sitagliptin Withdrawal Study (MK-0431-845)

Clinical trial NCT02738879 · COMPLETED

Trial details

NCT number
NCT02738879
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-05-09
Primary completion
2018-01-22
Enrollment
746

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.